Skip to content

VITROLIFE: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

VITROLIFE

BE 0685.675.182
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€167,338
2024 · €195,989-€28,651
Equity
€1.0m
2024 · €880,450+€167,338
Cash
€546,003
2024 · €1.2m-€682,617
Balance sheet total
€2.2m
2024 · €2.4m-€132,469

Largest movements

2024 to 2025
Assets
  • Cash -€682,617

    down €682,617 (-55.6%), from €1.2m to €546,003

    mainly Trade debts (-€525,556) and Receivables within one year (-€419,561)

  • Receivables within one year +€419,561

    up €419,561 (+38.1%), from €1.1m to €1.5m

    of which Trade receivables: +€482,743

  • Deferred charges and accrued income +€131,181

    up €131,181 (+260.1%), from €50,430 to €181,611

Equity and liabilities
  • Trade debts -€525,556

    down €525,556 (-43.7%), from €1.2m to €677,781

  • Profit (loss) carried forward +€167,338

    up €167,338 (+19.5%), from €859,990 to €1.0m

  • Other debts +€101,167

    up €101,167 (+286.1%), from €35,357 to €136,524

  • Tax, wage and social debts +€63,232

    up €63,232 (+32.5%), from €194,788 to €258,020

    of which Remuneration and social security: +€35,069

  • Provisions +€40,421

    new in 2025: €40,421

Income statement
  • Gross operating margin +€456,327

    up €456,327 (+37.1%), from €1.2m to €1.7m

  • Staff costs +€443,251

    up €443,251 (+45.6%), from €973,089 to €1.4m

  • Provisions +€40,421

    new in 2025: €40,421

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €195,989
Gross operating margin +€456,327
Staff costs -€443,251
Depreciation +€492
Write-downs -€4,033
Provisions -€40,421
Other operating charges +€968
Financial income -€7,205
Financial charges -€332
Taxes +€8,804
Result 2025 €167,338

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€682,617
Investment €0
Financing €0
Cash 2024 €1.2m
Net result for the year +€167,338
Depreciation +€594
Receivables within one year -€419,561
Deferred charges and accrued income -€131,181
Provisions +€40,421
Trade debts -€525,556
Tax, wage and social debts +€63,232
Other debts +€101,167
Accrued charges and deferred income +€20,929
Cash 2025 €546,003
Every line side by side 44 lines
Line Code 2024 2025 Change %
Total assets 20/58 €2,381,757 €2,249,288 -€132,469 -5.6%
Fixed assets 21/28 €991 €396 -€594 -60.0%
Tangible fixed assets 22/27 €991 €396 -€594 -60.0%
Plant, machinery and equipment 23 €991 €396 -€594 -60.0%
Current assets 29/58 €2,380,767 €2,248,892 -€131,874 -5.5%
Amounts receivable within one year 40/41 €1,101,718 €1,521,279 +€419,561 +38.1%
Trade receivables 40 €998,516 €1,481,258 +€482,743 +48.3%
Other amounts receivable 41 €103,202 €40,020 -€63,181 -61.2%
Cash at bank and in hand 54/58 €1,228,619 €546,003 -€682,617 -55.6%
Deferred charges and accrued income 490/1 €50,430 €181,611 +€131,181 +260.1%
Total equity and liabilities 10/49 €2,381,757 €2,249,288 -€132,469 -5.6%
Equity 10/15 €880,450 €1,047,788 +€167,338 +19.0%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €1,860 €1,860 = 0.0%
Non-distributable reserves 130/1 €1,860 €1,860 = 0.0%
Reserves not available under the articles 1311 €1,860 €1,860 = 0.0%
Profit (loss) carried forward 14 €859,990 €1,027,328 +€167,338 +19.5%
Provisions and deferred taxes 16 - €40,421 +€40,421
Provisions for liabilities and charges 160/5 - €40,421 +€40,421
Other liabilities and charges 164/5 - €40,421 +€40,421
Amounts payable 17/49 €1,501,308 €1,161,080 -€340,228 -22.7%
Amounts payable within one year 42/48 €1,433,482 €1,072,325 -€361,157 -25.2%
Trade debts 44 €1,203,337 €677,781 -€525,556 -43.7%
Suppliers 440/4 €1,203,337 €677,781 -€525,556 -43.7%
Taxes, remuneration and social security 45 €194,788 €258,020 +€63,232 +32.5%
Taxes 450/3 €30,519 €58,682 +€28,164 +92.3%
Remuneration and social security 454/9 €164,270 €199,338 +€35,069 +21.3%
Other amounts payable 47/48 €35,357 €136,524 +€101,167 +286.1%
Accrued charges and deferred income 492/3 €67,825 €88,754 +€20,929 +30.9%
Remuneration, social security and pensions 62 €973,089 €1,416,340 +€443,251 +45.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,086 €594 -€492 -45.3%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 - €4,033 +€4,033
Provisions for liabilities and charges: additions (uses and reversals) 635/8 - €40,421 +€40,421
Other operating charges 640/8 €968 - -€968
Gross operating margin 9900 €1,228,524 €1,684,851 +€456,327 +37.1%
Operating profit (loss) 9901 €253,382 €223,464 -€29,918 -11.8%
Financial income 75/76B €16,307 €9,102 -€7,205 -44.2%
Recurring financial income 75 €16,307 €9,102 -€7,205 -44.2%
Financial charges 65/66B €1,714 €2,046 +€332 +19.4%
Recurring financial charges 65 €1,714 €2,046 +€332 +19.4%
Profit (loss) for the period before taxes 9903 €267,974 €230,519 -€37,455 -14.0%
Income taxes 67/77 €71,986 €63,181 -€8,804 -12.2%
Profit (loss) for the period 9904 €195,989 €167,338 -€28,651 -14.6%
Profit (loss) for the period to be appropriated 9905 €195,989 €167,338 -€28,651 -14.6%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 11 October 2026 via checked.be.